LSI Asia – Day 1
The first day of the LSI Asia’s Emerging Medtech conference in Singapore has been superb – and particularly pleased with the response from my presentation on our Callavid® vaginal drug delivery platform. Driven by growing regional concerns over declining fertility and birth rates across Asia, our initial focus on supporting IVF and miscarriage prevention has …
Need & Network: An Evening of Connection in Women’s Health
Great networking evening at Calla Lily Clinical Care last night. Such a diverse group of people interested in women’s health spent the evening NOT MOANING but brainstorming on ways we can work together to change the world. The power of the network to find solutions through collective action. Thank you to my awesome team for …
Scheilly Tsilova PhD joins as Senior Pharmaceutical Scientist
We’re delighted to welcome Scheilly Tsilova, Ph.D to the Calla Lily Clinical Care team as our new Senior Pharmaceutical Scientist. 🥼 For the past two years, Scheilly has been instrumental in advancing our Callavid® vaginal drug delivery technology while pursuing her PhD at UCL, with a focus on polymer-based drug delivery systems. Her deep technical …
ACOG in Minneapolis
Spending time in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting was even better than I had hoped. Besides the constant engagement with passionate American OBGYNs (so many of which are excited to hear about our Callavid® drug delivery technology) – it was superb to connect with other …
HLTH Europe Startup Finalist
Delighted to be named a 2025 finalist in the HLTH Europe Startup Pitch, sponsored by Haleon! Honoured to share the stage with some of the most innovative healthtech startups in Europe. See you in Amsterdam. 🇳🇱
Naomi Aduroja joins as a Roivant Social Ventures Global Access Fellow
💥 A warm welcome to Naomi Aduroja who joins us as a Roivant Social Ventures Global Access Fellow this summer. Currently preparing for her third year in the prestigious PharmD program at UNC Eshelman School of Pharmacy – we’re delighted to have Naomi support various R&D projects leaning on her experience including from across pharmacy …
ACOG Clinical & Scientific Meeting in Minneapolis
We’re delighted to be in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting. From May 16th-18th, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at the largest meeting of obstetricians and gynecologists in the US. This is an exciting opportunity to discuss …
Discover CLCC’s B Corp Impact Report
We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …
CLCC awarded £1m NIHR funding to address threatened miscarriage
Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials • Scientists developing a pioneering device designed to address threatened miscarriage have secured £1 million in NIHR funding to begin clinical trials • Designed to deliver vital doses of progesterone, the Callavid® device stands to help over 150,000 women each …
Int’l Women’s Day
A slightly belated nod to International Women’s Day (as we’ve just taken this 📸 )— but still just in time for Women’s History Month. I want to take a moment to share how incredibly grateful I am to work alongside such a brilliant, dedicated, and inspiring group of women at Calla Lily Clinical Care 🔬 It’s …